Skip to main content

Table 1 Baseline characteristics of study sample

From: Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway

 

Percentages or Mean (SD)

Patients, na

Gender, n = 609

  Male

71%

  Female

29%

Age, n = 609

   < 25

3%

  26–40

39%

  41–60

53%

   ≥ 61

5%

  Mean age (SD)

44 (10)

Current OAT medication, n = 588

  Methadone

38%

  Buprenorphine

56%

  Buprenorphine/naloxone

4%

  Other

2%

  Duration of OAT treatment in years, mean (SD), n = 583

7.9 (5.4)

Background demographics

  Highest level of completed education, n = 588

  Did not complete primary and secondary school

5%

  Completed primary and secondary school

45%

  High school

40%

  Undergraduate education ≤3 years

8%

  Postgraduate education ≥3 years

2%

  Main source of income, several answers possible, n = 611

  Paid work (full time or part time)

7%

  Sick pay or unemployment benefits

10%

  Social or disability benefits

79%

  Savings or scholarships

1%

  Other

3%

 Accommodation last 30 days several answers possible, n = 606

  Owned property

9%

  Rented property

68%

  Temporary property

7%

  Prison

1%

  Homeless

1%

  At friends or family

12%

  Other

2%

 Living conditions n = 586

  Living alone

63%

  Living with others

37%

 Children n = 587

  Do not have children

44%

  Have children

56%

 For those having children < 18 years old, n = 152

  Having children < 18 with visiting rights

79%

  Having children < 18, but no visiting rights

21%

  1. OAT Opioid agonist therapy, SD Standard deviation,
  2. an = number of respondents, some questions allow multiple answers